Core Viewpoint - China Tianhua Chemical (00362) has received letters from the Stock Exchange regarding the resumption of trading of its shares, outlining specific conditions that must be met for the resumption to occur [1] Group 1 - The company must revoke or dismiss any liquidation orders against it and remove any liquidators [1] - The company is required to demonstrate compliance with Listing Rule 13.24 [1] - The company must disclose all significant information to allow shareholders and other investors to assess its condition [1] Group 2 - The company is obligated to publish all outstanding financial results in accordance with listing rules and address any audit revisions [1] - The company's shares remain suspended from trading [1]

Core Viewpoint - China Tianhua Chemical (00362) has received letters from the Stock Exchange regarding the resumption of trading of its shares, outlining specific conditions that must be met for the resumption to occur [1] Group 1: Resumption Conditions - The company must withdraw or dismiss any liquidation orders against it and remove any liquidators [1] - The company needs to demonstrate compliance with Listing Rule 13.24 [1] - The company is required to disclose all significant information to allow shareholders and other investors to assess its condition [1] - The company must publish all outstanding financial results in accordance with listing rules and resolve any audit revisions [1] Group 2: Current Status - The company's shares remain suspended from trading [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部分內容而產生或因依 賴該等內容而引致的任何損失承擔任何責任。 China Zenith Chemical Group Limited 中國天化工集團有限公司 （強制清盤中） （於開曼群島註冊成立並於百慕達存續之有限公司） （股份代號：362） (1) 最新發展之季度更新; 本公告乃中國天化工集團有限公司（強制清盤中）（「本公司」，連同其附屬公司統 稱「本集團」）根據香港聯合交易所有限公司（「聯交所」）證券上市規則（「上市 規則」）第 13.09 條及第 13.24A 條，以及香港法例第 571 章證券及期貨條例第XIVA部 之內幕消息條文（定義見上市規則）作出。 茲提述本公司日期分别為 2025 年 4 月 17 日及 2025 年 11 月 21 日的公告（「該等公 告」），其中包括對本公司作出的清盤令以及共同及各別清盤人的任命。除另界定外， 本公告所用詞彙與該等公告所界定者具有相同涵義。 最新發展之季度更新 誠如該等公告所述，根據高等法院於 2025 年 10 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年11月30日 狀態: 新提交 致：香港交易及結算所有限公司 II. 已發行股份及/或庫存股份變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) 是 | | | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00362 | 說明 | | | | | | | | 已發行股份（不包括庫存股份）數目 | | 庫存股份數目 | 已發行股份總數 | | | 上月底結存 | | | 1,351,548,168 | | 0 | 1,351,548,168 | | 增加 / 減少 (-) | | | | | | | | 本月底結存 | | | 1,351,548,168 | | 0 | 1,351,548,168 | 公司名稱: 中國天化工集團有限公司（於開曼群島註冊成立並於百慕達存續之有限公司） 呈交日期: 2025年12月1日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 ...

Core Viewpoint - China Tianhua Chemical (00362) has announced the appointment of joint and individual liquidators following a court order from the High Court dated October 31, 2025 [1] Group 1 - The joint and individual liquidators appointed are Mr. Ma De Min and Mr. Li Yong Lin from Kai Jin Enterprise Consulting Co., Ltd [1] - The appointment of the liquidators is effective from October 31, 2025, granting them authority as the company's representatives [1]

Core Viewpoint - China Tianhua Chemical (00362) has announced the appointment of joint and individual liquidators following a court order from the High Court dated October 31, 2025 [1] Group 1 - The joint and individual liquidators appointed are Mr. Ma Demin and Mr. Li Yung Lin from Kaijin Enterprise Consulting Co., Ltd [1] - The appointment of the liquidators is effective from October 31, 2025, granting them authority as the company's representatives [1]

Core Viewpoint - China Tianhua Chemical (00362.HK) has announced the appointment of joint and several liquidators following a court order, indicating significant corporate restructuring and potential insolvency issues [1] Group 1: Company Announcement - The High Court appointed Ma De Min and Li Ying Lin from Kai Jin Corporate Advisors Limited as joint and several liquidators of the company as of October 31, 2025 [1] - The company's executive director and authorized representative, Sheng Pin Ru, passed away on August 18, 2025 [1] - Trading of the company's shares has been suspended on the Hong Kong Stock Exchange since 10:28 AM on March 17, 2025, and will remain suspended until further notice [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部分內容而產生或因依 賴該等內容而引致的任何損失承擔任何責任。 China Zenith Chemical Group Limited 中國天化工集團有限公司 （強制清盤中） （於開曼群島註冊成立並於百慕達存續之有限公司） （股份代號：362） (1) 委任共同及各別清盤人； 委任共同及各別清盤人 中國天化工集團有限公司（強制清盤中）（「本公司」）的共同及各別清盤人謹此宣 佈，根據高等法院於 2025 年 10 月31 日所作的命令（「該命令」），凱晉企業顧問有 限公司的馬德民先生及黎頴麟先生獲委任為本公司的共同及各別清盤人。 更改香港主要營業地點及聯絡方式 本公司謹此宣佈，自 2025 年 10 月 31 日起，本公司的香港主要營業地點、聯絡電話、 傳真號碼及電郵地址更改如下﹕ 地址 ﹕ 香港銅鑼灣恩平道 28 號利園二期 29 樓 聯絡電話 ﹕ (852) 2583 1313 傳真號碼 ﹕ (852) 2566 8946 電郵地址 ﹕ chinazeith@ac ...

Core Viewpoint - The Hong Kong Securities and Futures Commission (SFC) and the Independent Commission Against Corruption (ICAC) have intensified their efforts to combat market manipulation and corruption, as evidenced by recent joint operations targeting a sophisticated criminal group involved in fraudulent activities related to a listed company, China Tianhua Chemical Holdings (00362.HK) [1][3][4]. Group 1: Recent Enforcement Actions - On July 25, the SFC announced a joint operation with the ICAC, resulting in the search of 14 locations and the arrest of key individuals, including a former chairman and executive director of a listed company, for allegedly conspiring to use false documents and manipulate stock prices [1][4]. - The arrested individuals are suspected of being involved in a scheme that falsely claimed a share subscription agreement with a mainland enterprise, involving over HKD 20 million [1]. - The SFC has been actively investigating suspicious trading activities and has referred cases to the ICAC for corruption investigations, highlighting a collaborative approach to tackling market misconduct [1][5]. Group 2: Impact on the Market - The enforcement actions are part of a broader strategy by the SFC to enhance market integrity and investor confidence, especially in light of a strong recovery in the Hong Kong IPO market, which saw 42 companies raise HKD 107.1 billion in the first half of 2025, a sevenfold increase year-on-year [7]. - The SFC's proactive measures, including the issuance of transaction record requests and asset restrictions on brokerage firms, aim to mitigate risks associated with IPOs and ensure the long-term health of the market [7]. - The focus on combating corruption and market manipulation is crucial for maintaining Hong Kong's reputation as a financing hub and ensuring a balance between growth and quality in the capital market [7].

Financial Performance - For the six months ended December 31, 2024, the turnover decreased by 13% to HK$21,523,000 compared to HK$24,733,000 in the same period of 2023[3]. - The loss for the period improved by 19% to HK$69,006,000 from HK$85,592,000 year-on-year[3]. - Basic loss per share decreased significantly by 69% to HK(4.92) cents from HK(15.85) cents in the previous year[3]. - Gross profit for the period was HK$3,057,000, down from HK$7,357,000, indicating a decline in profitability[6]. - The total comprehensive expense for the period was HK$69,650,000, compared to HK$65,147,000 in the previous year[10]. - Revenue from external customers for the six months ended December 31, 2024, was HK$21,523,000, a decrease from HK$24,733,000 in the same period of 2023, representing a decline of approximately 12.5%[63]. - The segment loss for Calcium carbide was HK$13,844,000, while the Agricultural chemicals segment reported a loss of HK$2,519,000, contributing to a total segment loss of HK$69,006,000 for the period[63]. Assets and Liabilities - As of December 31, 2024, total assets decreased to HK$380,916,000 from HK$478,100,000 as of June 30, 2024, representing a decline of approximately 20.4%[12]. - Non-current assets fell from HK$427,868,000 to HK$350,335,000, a decrease of about 18.1%[12]. - Current assets decreased significantly from HK$50,232,000 to HK$30,581,000, a reduction of approximately 39.1%[12]. - Total liabilities decreased slightly from HK$1,487,244,000 to HK$1,459,710,000, a decline of about 1.9%[14]. - The company's total deficit increased from HK$1,009,144,000 to HK$1,078,794,000, reflecting an increase of approximately 6.9%[14]. - The equity attributable to owners of the Company decreased from HK$1,008,984,000 to HK$1,076,227,000, indicating a decline of about 6.7%[16]. - The Group's current ratio was approximately 0.1, and the gearing ratio was 383% as of December 31, 2024[142]. Cash Flow and Financing - For the six months ended December 31, 2024, the net cash generated from operating activities was HK$ (6,283,000), a decrease from HK$ 5,730,000 in the same period of 2023[20]. - The net cash generated from investing activities was HK$ 71,750,000, compared to a cash outflow of HK$ (1,840,000) in the previous year[20]. - The net cash used in financing activities increased significantly to HK$ (95,031,000) from HK$ (5,928,000) in the prior year[20]. - The Group's bonds payable increased from HK$1,064,706,000 on June 30, 2024, to HK$1,115,732,000 by December 31, 2024[101]. - Interest charges for the period ending December 31, 2024, amounted to HK$48,318,000, compared to HK$81,902,000 for the previous period[101]. - The Group plans to issue up to 50 bonds on February 21, 2025, with a principal amount of HK$1,000,000 each, totaling a maximum of HK$50,000,000, at an interest rate of 10% per annum[118]. Operational Highlights - The company did not declare any interim dividend for the period[3]. - The company maintained strict control over outstanding receivables, with overdue balances regularly reviewed by management[85]. - The company is negotiating a settlement for a bond payable of approximately HK$ 465 million, with expectations of deferring or discounting approximately HK$ 233 million of the bond payable[29]. - The management is optimistic about the recovery of the PRC economy and plans to actively resume calcium carbide production to improve profit margins in agricultural chemical products[181][184]. - The company is exploring opportunities for overseas market expansion and strategic investments to enhance shareholder value[182][185]. Employee and Cost Management - Staff costs, excluding directors' emoluments, totaled HK$5,165,000 for the period, compared to HK$4,707,000 in the previous year, reflecting an increase of approximately 9.7%[76]. - Administrative expenses were reduced to HK$27,729,000 from HK$32,173,000, reflecting cost control measures[6]. - Cost-cutting measures will be implemented to reduce administrative expenses and cash outflows over the next twelve months[36]. Share Capital and Equity - The company issued a total of 280,000,000 shares at a placement price of HK$0.10 per share, raising approximately HK$22,400,000 for debt repayment and general working capital[98]. - The total issued and fully paid ordinary shares as of December 31, 2024, remained at 1,351,548,168 shares, unchanged from June 30, 2024[90]. - The company converted approximately HK$28,560,000 of convertible bonds into 136,000,000 shares at a conversion price of HK$0.21 per share[97]. Market and Economic Conditions - The group has minimal foreign currency risk as most transactions are in Hong Kong dollars and Renminbi, with no hedging instruments outstanding as of December 31, 2024[172][175]. - The management maintains a cautiously optimistic outlook on commodity prices, anticipating stabilization in the sales price of calcium carbide[187][190].